fbpx

Blog

Bushfire Support

The current bushfires across Australia have resulted in unprecedented demand on pharmacists working in multiple settings, especially in community pharmacy.
 
PSA have heard many stories and first hand examples of pharmacists going above and beyond in their support of their communities. We have also heard of barriers to accessing and providing care in these disaster affected zones.
 
PSA have been in contact with the Commonwealth Department of Health, the office of the Commonwealth Health Minister, and the Australian Defence Force. PSA will continue to provide advice to these agencies about the requirements on the ground.
 
Members who are experiencing challenges in delivering care to their local communities can email bushfires@psa.org.au and we will pass on your requirements to the relevant State and or Commonwealth Departments.
 
These issues may be in the context of the following

  • Logistical supplies of medicines
  • Workforce support
  • Power interruption
  • Payment of medicines
  • Mental health support for staff.

 
In the long term we will continue to address two major areas of concern for you and for your patients:

  • The need for more flexible emergency supply arrangements, especially in disaster periods
  • The need for meaningful support for community pharmacy in disaster planning and preparedness.

 
PSA are seeking advice regarding the supply of Schedule 3 medicines during this period from the relevant state health departments, and will provide advice when this available. In the absence of specific information from State health departments regarding the supply of medicines in these circumstances, including salbutamol, we urge pharmacists to exercise their professional judgment in the appropriate supply of medicines.
 
Times like this can be very hard, even for those not directly affected. If you or your staff require support, you can access the Pharmacists’ Support Service by calling 1300 244 910.
 
Beyond Blue have some good resources that you, your staff and community may find beneficial during this time, including this guide to looking after yourself in a disaster.
 
I hope and trust that you all remain safe.
 

A/Prof Chris Freeman
National President
Pharmaceutical Society of Australia

Next level intern training

The market leader that gives you more including FREE PSA membership and immunisation training.

 

My Health Record Guidelines

PSA, in partnership with the Australian Digital Health Agency, has developed Digital Health Guidelines that incorporate guidelines for pharmacists when utilising  My Health Record. These guidelines are designed to support meaningful clinical use of the My Health Record system.

 

The My Health Record provides a picture of an individual’s health information, supporting timely access to important clinical documents and Medicare information by patients and their treating healthcare providers.

 

PSA gratefully acknowledges the Australian Digital Health Agency for providing funding for this project.

 

Budget boost could help save lives

Monday, 16 November 2019

 

The Pharmaceutical Society of Australia has called on the Victorian Government to make Medication Assisted Treatment for Opioid Dependence (MATOD) more affordable in order to save lives.

 

In its 2020-21 Pre-Budget Submission, PSA identified four priority areas of action where funding will have a significant impact on health care and outcomes.
“Australian Bureau of Statistics (ABS) data suggests 298 people in Victoria lost their lives last year due to opioid induced deaths.” Pharmaceutical Society of Australia Victorian President, Ben Marchant said. “Every one of these members of our community were someone’s friend or family member and leave behind grieving loved ones.”

 

MATOD programs support people living with a substance use disorder and provide stability and a pathway to rehabilitation through daily dosing of long-acting opioid medicines such as methadone.

 

PSA understands there are approximately 14,000 people currently utilising the program in Victoria, but there are substantial barriers to access.

 

“Cost is a significant barrier,” Mr Marchant explained. “While the medicines are free, the cost for safe, witnessed dosing is currently met by the patient. This is out of step with other states where these services can be fully government funded.”

 

In Victoria, MATOD services are nearly exclusively provided through community pharmacies.

 

“We are proposing a co-payment model. The Victorian Government would provide funds for this service in order to reduce patient out of pockets costs – making access more affordable – while ensuring pharmacists are adequately remunerated and able to offer this important service,” Mr Marchant said.

 

PSA has also warned that some of Victoria’s most vulnerable population groups, including children, the ill, elderly and infirm, are being put at risk due to the low vaccination rates of those who care for them.

 

“For example, less than 50 per cent of childcare workers are fully vaccinated and seasonal influenza vaccination uptake is inconsistent in aged care and health care workers,” Mr Marchant revealed.

 

To increase vaccination rates in Victoria, PSA is recommending expanding the range of vaccines trained pharmacists are able to administer in line with proposals in the current Department of Health and Human Services (Victoria) vaccination consultation and to include all vaccines recommended for health care workers and carers.

 

PSA’s Pre-Budget Submission also calls on the Government to establish the role of Victorian Chief Pharmacist and allocate $500,000 to upskill pharmacists in mental health first aid.

 

“Nearly half of all Australians will experience a mental health illness in their lifetime,” Mr Marchant said. “Mental health challenges are even more common in rural and remote areas where pharmacists are often the most accessible healthcare professional.

 

“Pharmacists are well placed to support patients in the community and identify them early so they can be referred to appropriate mental health providers, including general practitioners.

 

In Victoria, there are 7,443 registered pharmacists working in community pharmacies, hospital, general practice, aged care, Victorian and federal government and within other private sector organisations.

 

PSA’s Victorian Budget submission can be found here.

 

Media contact: Stefanie Johnston, PSA Victoria – 0417 910 738

 

Download media release

Budget an opportunity to improve health care for Tasmanians

The state’s 784 registered pharmacists could help significantly improve the health of Tasmanians with implementation of a few relatively low cost or no-cost measures, the Pharmaceutical Society of Australia has championed in its 2020-21 Pre-Budget Submission.

 

A key recommendation is to more fully utilise pharmacists in the provision of after-hours care for minor ailments.

 

“For a whole raft of reasons our emergency departments are under immense pressure,” PSA Tasmania President, Dr Ella van Tienen said. “Contributing to the burden are the number of presentations by patients with less-serious ailments, such as minor pain management or cold and flu.

 

“Recent research shows pharmacists have the skills and expertise to support patients who would currently seek care from a GP or hospital. Pharmacists can provide self-care advice, which in most cases is what is needed, or triage patients and refer them to the appropriate health service.

 

“Pharmacists are located throughout our local communities and a network are already open after-hours, making them well placed to do more. We estimate this initiative could save Tasmania’s health budget over $4 million a year.”

 

PSA is seeking funding of $2 million for a two-year pilot program under which pharmacists spread geographically access the state are incentivised to offer expanded after-hours service.

 

The budget submission also calls for $700,000 to enable a dedicated medicine safety pharmacist to work in each of the state’s five adult mental health services.

 

“Tasmania’s mental health outpatient facilities provide care to some of the most vulnerable members of our community. Medicines are a major treatment modality for many people with a mental illness and due to the nature of these medicines and complexity of medication regimes, there is increased risk of medication error and harm,” Dr van Tienen explained.

 

“Tasmania actually has the highest proportion of people dispensed with mental health-related prescriptions. To ensure these medicines are used safely we would like pharmacists more actively involved in the care team.”

 

Enabling pharmacists to provide a broader range of vaccinations would help further protect Tasmanians against preventable infectious diseases, PSA has argued.

 

“While this year has seen an expansion in scope of vaccines administered by pharmacists, we still lag behind other states in terms of allowing pharmacists to provide eligible Tasmanians with access to vaccines funded on the National Immunisation Program (NIP), such as influenza vaccinations” Dr van Tienen said. “With pharmacists located in rural and remote areas where other health professionals may be limited, these communities would benefit from access to NIP vaccinations through their local pharmacy.”

 

Supporting pharmacists to provide HPV and Hepatitis A vaccinations will also help remove barriers limiting Tasmanians from getting vaccinated and increase herd immunity.

 

“With around 200 pharmacist immunisers already fully trained, this recommendation could be quickly, cost effectively and safely implemented,” Dr van Tienen said. “In fact, we believe there is no direct budget investment required.

 

The second nil cost measure proposed by PSA is to expand the current pilot of the Hospital Liaison Pharmacist program to link back into the patient’s community pharmacists and ensure safe transfer of care at discharge.

 

“In terms of their health care journey, the point of hospital discharge presents one of the highest risks of medication error,” Dr van Tienen said. “Over 90 per cent of patients have at least one medication related problem post-discharge from hospital. As their community pharmacist is most likely to be the first health care provider a patient sees after hospital discharge the pharmacist can help patients understand, manage and adhere to their medication regime and prevent avoidable readmissions, but only if they are fully informed.”

 

PSA’s 2020-21 Tasmanian Budget Submission is available here.
Dr Ella van Tienen is available for interview and photographs

 

Media contact: Ella van Tienen 0419 335 893, media@psa.org.au

Health sector unites to turn the tide on medicine safety

Monday 9 December 2019

 

 

Better use of existing funding, leveraging digital health, empowering consumers and the workforce are among the keys to thinking and acting differently on medicine safety.

 

These were the themes resonating at a forum of stakeholders representing the breadth of health care, including government and consumers, held in Canberra today.

 

Convened by the Consumers Health Forum of Australia (CHF), Pharmaceutical Society of Australia (PSA), the Society of Hospital Pharmacists of Australia (SHPA), NPS MedicineWise and academic partners Monash University and University of Sydney, participants were challenged to ‘think differently’ on the safe use of medicines in Australia to turn the tide on this major health challenge.

 

“Medicine safety is a priority for us all and we each have a role to play,” PSA National President Associate Professor Chris Freeman said. “It was inspiring to see the sector work together today to proactively identify those measures we can cooperatively pursue to make a real difference and protect patients.”

“Improving medicine safety is not just about spending more money but also about being more strategic with the money that is spent.”
Medicine safety and quality use of medicines was recently declared the 10th National Health Priority Area by Commonwealth and state and territory health ministers.

 

CHF CEO, Leanne Wells, said: “Discussions often returned to how vital it is to have patients actively engaged in their health care decisions and informed about the medicines they are prescribed.

 

“Modern medication offers great benefits but the rate of hospital admissions caused by avoidable medication errors shows the importance of ensuring consumers are informed about their medicines, which is an integral part of broader quality use of medicines.

 

SHPA Chief Executive Kristin Michaels said: “The Medicine Safety Forum represents collaborative medicine leadership, which is crucial to ensuring Australians gain the greatest possible benefit from medicine use.

 

“The successful combination of effective medicine, provided in an accessible manner, with appropriate counselling and care from an expert workforce, will deliver the positive patient outcomes we all seek.”

 

NPS MedicineWise CEO Steve Morris said: “We need to cherish the ethos of quality use of medicines. While Australia’s National Strategy for the Quality Use of Medicines requires an update, the principles of 20 years ago, including the primacy of consumers, is just as relevant today.”

 

The cost of medicine-related harm is significant, estimated at more than $1.4 billion each year.

 

“Today there was deep discussion of the actions we can take to reduce harm from medicines. We will now take the feedback and ideas we received from participants and develop a suite of recommendations and work with relevant stakeholders to implement as a matter of urgency,” Associate Professor Freeman said.

 

“We’d like to thank the more than hundred experts who joined us today and thought outside the box to address one of Australia’s greatest healthcare challenges.
“The depth and number of participants at today’s Forum shows how important this issue is and how committed the health care sector is to improving medicine safety.”

 

A report on the outcomes of the Medicine Safety Forum, including recommendations will now be developed.

 

Media contact: PSA Media – 0487 922 176
Consumers Health Forum – Mark Metherell 0429 111 986
SHPA – Nick Sharp-Paul 0411 098 838

 

Download the media release here

My Health Record a key to medicine safety

The Pharmaceutical Society of Australia believes the My Health Record system can significantly contribute to improved medicine safety in Australia and welcomes the Commonwealth’s commitment to continually improving this important digital health program.
 
This week the Digital Health Agency agreed to all five recommendations made by the Australian National Audit Office in its report Implementation of the My Health Record System.
 
“Overall, the report found implementation has been largely effective. Its recommendations focus on privacy and security of health information and the Digital Health Agency has undertaken to work with stakeholders to raise standards in health information management,” Pharmaceutical Society of Australia National President, Associate Professor Chris Freeman said.
 
“Uptake and participation are vital to the success of My Health Record. Therefore, ensuring both providers and patients are confident information is safe is essential.”
 
PSA is pleased the participation rate for pharmacies stands at 90 per cent, but would like to see more utilisation across the health care sector.
 
“The usage for healthcare provider organisations is growing and we’d certainly hope that as people come to understand the benefits this tool offers, we see that quickly increase.
 
“My Health Record’s potential to improve health care and save lives relies on the quality of information contained.”
 
PSA’s Medicine Safety: Take Care report highlighted the impact a shared digital health record can have on care.
 
National implementation of the My Health Record will help pharmacists improve medicine safety. Access to a complete medication history will provide pharmacists with the opportunity to proactively intervene to both document and reduce adverse reactions, with improved documentation leading to less use of contraindicated therapy and the availability of the complete medication history enabling better detection of multi-medicine interactions.
 
The availability of hospital discharge summaries within My Health Record will provide the opportunity for pharmacists to proactively prevent and resolve medication-related problems post-discharge with medication reconciliation and review.
 
Media contact:PSA Media Phone 0487 922 176 media@psa.org.au
 

Download the media release here

Investment in medicines safety in aged care welcomed by PSA

25/11/2019
 
Today’s Federal Government announcement of significant investment to address the challenges of medicines safety in aged care, including reducing chemical restraint, has been welcomed by the PSA.
 
The $25.5 million to improve medication management programs to reduce the use of medicines as a chemical restraint on aged care residents and at home will support pharmacists to ensure that more medication reviews can occur.
 
“The Government’s decision to allow more medication reviews to be delivered to a section of our community in dire need of this critical intervention is to be applauded,” PSA National President Associate Professor Chris Freeman said
 
“The PSA has long advocated for a cycle of care that delivers medication reviews conducted at a frequency and level that is dependent on patient needs, with meaningful follow-up, rather than being arbitrarily capped by funding restrictions.”
 
The pivotal Medicine Safety: Take Care report released by PSA this year showed that 98% of residents in aged care facilities have at least one medicine-related problem and over half are exposed to at least one potentially inappropriate medicine.
 
“The Federal Government’s announcement acknowledges the important role of pharmacists in ensuring the safe and quality use of medicines for elderly Australians.
 
“It is essential, if we are to address the inappropriate use of medicines for older Australians that pharmacists are able to spend more time on the ground in residential aged care facilities and in patients’ homes delivering this vital service.”
 
PSA has also welcomed the provision of $10 million to increase dementia training and support for the aged care workforce.
 
Pharmacists can be the key to rolling out these education programs to doctors and nurses within aged care. These measures will go some way towards delivering more time on the ground for pharmacists to assist doctors and nurses to make the right decisions about the use of medicines in aged care, including when to use them and when to stop.
 
“Medicine safety is everybody’s responsibility. Ensuring pharmacists have a role in supporting activities from education through to clinical governance can help deliver comprehensive and system level improvements in aged care and for elderly Australians,” A/Prof Freeman said.
 
This announcement follows the Federal Government’s commitment last month to make medicine safety and the quality use of medicines a National Health Priority Area.
 
“As medicines experts, pharmacists must be supported to spend more time across the health care system reviewing patients’ medications, providing advice to other members of the health care team and educating consumers about medicines safety, including utilising the accessible network of community pharmacists,” A/Prof Freeman said.
 
“Today’s announcement acknowledges the importance of medicines safety at both the patient and system level and is a step in the right direction to ensure all Australians receive timely, equitable and efficient healthcare.”
 
Media contact: 0487 922 176 media@psa.org.au
 

Download the media release here

Leading local Victorian pharmacists honoured

22/11/2019
 
The three Victorian pharmacists honoured at last night’s Victorian Pharmacists Dinner represent not only the breadth of opportunities and experiences offered by a career in pharmacy, but the difference dedicated members of the profession make every day to health care in our community.
 
At last night’s ceremony, Roslyn Stewart from Broadford was awarded the Victorian Pharmacist Medal; Brighton’s Kay Dunkley received the Victorian Excellence Award, and Dr Amanda Cross of Albanvale was named Early Career Pharmacist of the Year.
 
Each of the award recipients have dedicated their careers to caring for those in the community most in need.
 
“Between them, Roslyn, Kay and Amanda have achieved excellence in areas of practice ranging from research and tertiary care to community pharmacy and aged care,” Pharmaceutical Society of Australia Victorian President, Ben Marchant said.
 
“During the more than 20 years Kay has committed to caring for patients, she has also been a leader in ensuring the health and wellbeing of her peers.
 
“While Amanda is still in the early years of her career as a pharmacist, she has already had a significant impact on medicine safety in Victoria, particularly in terms of protecting older people with cognitive impairment from medicine errors.”
 
“During Roslyn’s working life, she has helped advance the optimisation and standardisation of treatment regimens and been committed to improving mental health care.”
 
Victorian Excellence Award winner, Kay Dunkley has had a long-term involvement with the Pharmacists’ Support Service (PSS). She explains that: “PSS is about caring for each other within the pharmacy profession to ensure that as a profession we can care for the Australian community. I really value the generosity of the PSS volunteers in giving their time and energy to be there for their colleagues in times of stress.”
 
A highlight of Kay’s work has been “being able to make a difference to the lives of those we care for as pharmacists.”
 
In terms of being honoured for her contribution to health care in Victoria, Kay is quick to remember those who have been there for her. “I attribute this recognition to the various people who have influenced me throughout my career. It is always wonderful when someone you respect encourages and supports you.”
 
Reflecting on the path that brought her to pharmacy, Victorian Pharmacist Medal recipient, Roslyn Stewart goes back to her school holidays on her grandparents’ farm. “Each week we would take a trip into town and would always visit their friend, the local pharmacist at his shop. Over the years it © Pharmaceutical Society of Australia Ltd. I 2 became apparent to me what an important contribution he made to the wellbeing of the local community.”
 
For Roslyn, a career as a pharmacist has offered a diversity of options. “I have taken advantage of this, working in research, hospital and community pharmacy and have been conducting medication reviews in aged care facilities and in the community for over 20 years. I have enjoyed each new challenge. Few careers provide this type of flexibility.”
 
Volunteering is in Roslyn’s blood and being a Mental Health First Aid Instructor is just one way she gives back to the community. “People are not generally well informed about mental health issues in the rural areas and there are few services available to get help. Being trained as a MHFA has improved my listening skills and ability to counsel people experiencing mental health issues.
 
“Being recognised with this award has made to realise that through my work as a pharmacist I have made a difference and this gives me enormous satisfaction.”
 
Dr Amanda Cross, the inaugural Victorian Early Career Pharmacist of the Year, loves being a pharmacist, particularly being able to advance the profession and help people. Her focus on medication safety stems from her work as a community pharmacist and home medication review pharmacist.
 
“I would frequently see patients struggling with medicine adherence and commonly using inappropriate medicines. While I was able to help individual patients, I chose to do a PhD to try to make a difference on a larger scale.
 
“Medicine safety is important to me because as a pharmacist it is my responsibility to ensure people are taking the right medicines, at the right dose for the right duration to ensure the medicine is creating more benefit than harm.
 
If Amanda could give one message to other early career pharmacists it would be: “stand up and fight for the change you want to see in the world around you. If you want to improve the health of your patients, make a change in your community or expand the scope of pharmacy practice – find a way, even if it means following a non-traditional path.
 
Mr Marchant praised, “All three award winners do themselves and their profession proud and are exceptionally worthy recipients.”
 
Media contact: Stefanie Johnston, PSA Victoria – 0417 910 738
 

Download the media release here


2019 PSA Victoria Awards Winners – profiles

Kay Dunkley, Victorian Excellence Award
 
Kay Dunkley has worked in hospital and organisational pharmacy for over 20 years as well as conducting medication reviews in aged care and in the community.
 
Kay has a strong interest in the health and well-being of health professionals and especially the role of peer support. Kay has a long-term involvement with the Pharmacists’ Support Service, a group which has been providing telephone support for pharmacists in Victoria since 1995. In 2005, Kay became the Program Coordinator for the Pharmacists’ Support Service and has assisted the service to become an independent organisation which has expanded to provide support to pharmacists, interns and students throughout Australia. She has also helped develop a similar service for the medical profession in Victoria.
 
Kay currently coordinates both the Pharmacists’ Support Services and AMA Victoria Peer Support Service.
 
Until recently, Kay was also working part-time as a consultant pharmacist in Residential Aged Care Facilities and private homes.

Roslyn Stewart, Victorian Pharmacist Medal
 
Roslyn’s career has spanned over 40 years and included both clinical and community pharmacy.
 
Her first position was as a relieving pharmacist in Victorian country hospitals. From 1979-85 in her position of Senior Pharmacist in the Department of Clinical Pharmacology and Therapeutics at the Royal Melbourne Hospital she conducted drug audits. One of these was on antibiotic usage and the results from this were the impetus for the development of the Antibiotic Guidelines, the first of the many Therapeutic Guidelines booklets. These guidelines have been a major advancement in optimising and standardising treatment regimens.
 
For the past 20 years Roslyn has worked in community pharmacy.
 
She is a trained Mental Health First Aid (MHFA) Instructor and teaches Standard MHFA, Older Persons MHFA and MHFA for Suicidal Thoughts on a volunteer basis for Mitchell Suicide Prevention Network because she believes that education about mental health issues empowers people to reach out to those in need and reduces stigma.
 
Over the past few years Roslyn has been marking assignments for the medication review component of the Monash Postgraduate Studies in Clinical Pharmacy Practice.

Amanda Cross, Early Career Pharmacist of the Year
 
Amanda has worked across a diverse range of traditional and non-traditional roles. Amanda has been passionately involved with the PSA for many years, at the state level as Victorian Branch Vice President and on the Victorian and national Early Career Pharmacists (ECP) working groups.
 
In 2019 Amanda completed her PhD focused on the prevalence and impact of potentially inappropriate medication use in older people with cognitive impairment. Amanda is a talented early career researcher with a strong track record including eight peer reviewed research papers and 13 conference presentations, both national and international. She has also been recognised through multiple awards, including winning the 2018 Monash Faculty of Pharmacy Three Minute Thesis competition and received grant funding from the Victorian Therapeutic Advisory Group to conduct a medication safety study in older people with memory impairment.
 
Amanda is currently undertaking postdoctoral research as the only pharmacist in a team of allied health researchers at the Monash Department of Clinical Epidemiology, Cabrini Institute. Amanda’s current projects include examining barriers and enablers to deprescribing opioids to inform development of future interventions to reduce the inappropriate use of opioids for chronic non-cancer pain. She is also working with the Australian Commission on Safety and Quality in Health Care to implement the Osteoarthritis of the Knee Clinical Care Standards.
 
Amanda also works as an independent accredited HMR pharmacist and provides teaching and support to undergraduate students and supervising registered pharmacists to conduct a HMR as part of their journey towards accreditation.

ACT Budget an opportunity to improve health care for Canberrans

18/11/2019

 

The ACT could implement a number of no or low cost initiatives that would significantly improve health outcomes for Canberrans and reduce pressure on the region’s ‘at capacity’ emergency departments, the Pharmaceutical Society of Australia has advised in its 2020-21 Pre-Budget Submission.

 

“There are 625 registered pharmacists in the ACT working in community pharmacy, hospital, general practice, aged care, territory and federal government and within other private sector organisations,” revealed Pharmaceutical Society of Australia National President A/Prof Chris Freeman. “Across the territory there are 84 registered pharmacies who not only provide health care to our community but contribute to the local economy and employment.”

 

PSA has recommended four budget measures to the ACT Government it believes provide innovative solutions to address current health system challenges and improve the public health care system.

 

“The ACT has just experienced one of its worst flu seasons on record and had a number of cases of measles. Vaccination continues to be a vital health intervention in this country,” A/Prof Freeman said.

 

PSA has called for vaccinations to be more widely accessible through pharmacy.

 

“Pharmacists have been vaccinating Canberrans against influenza and pertussis since 2015 and pharmacist-administered vaccination has been shown to be safe, convenient and accessible. However, funding and availability of pharmacist-administered vaccination in the ACT has not kept pace with other jurisdictions,” A/Prof Freeman explained.

 

“While the training pharmacists complete to administer vaccines is similar to that of other health professionals, such as nurse practitioners, pharmacists are unable to provide eligible Canberrans with a similar level of access to vaccines funded on the National Immunisation Program.”

 

PSA has proposed allowing all authorised immunisers to provide the same range of vaccines and extending the age range to allow patients access comparable with other jurisdictions.

 

“This will improve access and equity for consumers and encourage public uptake of these vaccines by reducing financial barriers to vaccination,” A/Prof Freeman said. “Almost half of Canberra’s pharmacies are already set-up to deliver these vaccines, meaning this recommendation could be quickly and cost effectively implemented. In fact, we believe there is no direct investment required.”

 

Pressure on the hospital system could also be reduced by expanding pharmacists’ ability to provide care after hours for Canberrans with minor ailments and conditions.

 

PSA seeks the ACT Government’s commitment to provide funding of $2 million to support a 2-year pilot of formal triage and referral services in six geographically dispersed after-hours pharmacies.

 

The budget submission advocates for a full-time pharmacist within the Winnunga Nimmityjah Aboriginal Health and Community Services and for the ACT to become a signatory to the Public Hospital Reform with the Commonwealth.

 

 

Media contact: PSA Media – 0487 922 176

 

Download the media release here

 

Download report here